• Home
  • About Steve Woodruff
  • Contact
  • Let’s Talk!
  • About Impactiviti

Impactiviti blog

Best Practices in Vendor and Project Management

Feeds:
Posts
Comments
« Some Friday Diversions
“Drug Reps use Psychological Tactics…” »

Which Golden Rule is Yours?

August 2, 2007 by Steve Woodruff

gold-sm.jpgGolden Rule #1 – treat others the way you’d wish to be treated

Golden Rule #2 – do what’s necessary to maximize my gold

Business ethics can seem complicated. Frankly, I think most of it boils to down to a pretty straightforward choice:

Do I do what’s right? Or do I do what is expedient to try to ensure maximum (income/profitability/bonus/stock price/etc.)?

What is right? That’s a debate that can draw in threads from theology, philosophy, psychology, and other disciplines, but let’s not over-complicate it. How would you want to be treated in a similar circumstance?

You’re working on the clinical research side of a pharmaceutical company, and a promising drug candidate starts to show some anomalous results. Some potentially dangerous side effects. Not a whole lot, mind you, and just a bit of tweaking and data-scrubbing could get it below the threshold of statistical significance. The company has been investing millions into this product, and the pipeline is a bit thin. Do you report it? Do you “work the numbers”? Do you ignore and cover over the warning signs? How does all this impact your job?

Wrong questions. How about this – would I give this drug to my child?

You’re promoting a diabetes product out in the field. Let’s say it’s Avandia. You get a direct question from a physician about cardiovascular side effects. Maybe he’s leaning toward transitioning some patients to Actos, or trying out Januvia. Your quota numbers, and your potential quarterly bonus, dance before your eyes. Do you answer the question directly and forthrightly, or do you shuffle and shift?

And here’s the baseline question – if you were not employed by GSK, and you had your choice of medicines…what would you want to have prescribed for you?

Which Golden Rule do you follow? Here are two simple tests: do you like what you see when you look yourself in the mirror? And how do you sleep at night?

One company that seems to embody this principle-centered approach to business is Johnson and Johnson. However imperfectly it is followed by any given individuals in the company, J&J’s one-page Credo is a marvelous example of how to flesh out the Golden Rule – Golden Rule #1, that is – in a business philosophy:

Our Credo

We believe our first responsibility is to the doctors, nurses and patients,
to mothers and fathers and all others who use our products and services.
In meeting their needs everything we do must be of high quality.
We must constantly strive to reduce our costs
in order to maintain reasonable prices.
Customers’ orders must be serviced promptly and accurately.
Our suppliers and distributors must have an opportunity
to make a fair profit.

We are responsible to our employees,
the men and women who work with us throughout the world.
Everyone must be considered as an individual.
We must respect their dignity and recognize their merit.
They must have a sense of security in their jobs.
Compensation must be fair and adequate,
and working conditions clean, orderly and safe.
We must be mindful of ways to help our employees fulfill
their family responsibilities.
Employees must feel free to make suggestions and complaints.
There must be equal opportunity for employment, development
and advancement for those qualified.
We must provide competent management,
and their actions must be just and ethical.

We are responsible to the communities in which we live and work
and to the world community as well.
We must be good citizens – support good works and charities
and bear our fair share of taxes.
We must encourage civic improvements and better health and education.
We must maintain in good order
the property we are privileged to use,
protecting the environment and natural resources.

Our final responsibility is to our stockholders.
Business must make a sound profit.
We must experiment with new ideas.
Research must be carried on, innovative programs developed
and mistakes paid for.
New equipment must be purchased, new facilities provided
and new products launched.
Reserves must be created to provide for adverse times.
When we operate according to these principles,
the stockholders should realize a fair return.

Sure, J&J companies and employees fail to live up to this standard of excellence and fair play every day. But that doesn’t mean that the standard is wrong. Only that, at any given time, individuals choose themselves above others.

What is the root cause of the parade of scandals we see in Pharma (and, for that matter, in plenty of other industries)? Most of the time, we need look no further than Golden Rule #2.

We moan and groan about Sarbanes-Oxley, OIG, regulatory meddling, whistleblowing, and all the other thorny features of rules and disclosures that address wrongdoing. But who is to blame? All those who lead their companies, their teams, and themselves by Golden Rule #2.

I’d love to see some pharma CEO take a stand squarely on Golden Rule #1 and drive it throughout the entire organization, come whatever may. The short-term disruption would pale compared to the long-term benefit.

A peaceful conscience and an intact reputation – priceless.

Share this:

  • Twitter
  • Facebook
  • Email

Like this:

Like Loading...

Posted in Business, Ethics, J&J, Pharma, Pharmaceutical | 1 Comment

One Response

  1. on September 19, 2007 at 8:39 am It Stinks Around Here « Impactiviti blog

    […] pretty simple, really – if you love the gold more than the Golden Rule, you’ll stink. No P.R. strategy or cover-up will save you. You’ll invite government […]



Comments are closed.

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Subscribe to our e-newsletter

    Sign up for the Impactiviti Connection!
  • Subscribe to the blog!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Recent Posts

    • Try Out the Random Vendor Generator!
    • Clocks, Toddlers, and Project Management
    • What are you delivering (via LMS)?
    • Today’s Pharma News 8/18/2017
    • Today’s Pharma News 8/16/17
    • Today’s Pharma News 8/15/17
    • Today’s Pharma News (8/14/17)
    • Lighting “afar” in Nashville – LTEN 2017 re-cap
    • Let’s Stop Committing Training Malpractice!
    • Getting Ready for Nashville 1-2-3-4!
  • Archives

    • November 2017
    • October 2017
    • August 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • June 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • October 2014
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006

Create a free website or blog at WordPress.com.

WPThemes.


  • Follow Following
    • Impactiviti blog
    • Join 30 other followers
    • Already have a WordPress.com account? Log in now.
    • Impactiviti blog
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d bloggers like this: